Airbus delivers 75 aircraft in Q1 amid Boeing woes- Barclays

Barclays estimates Airbus delivered 75 aircraft in Q1 2026 through March, with 21 delivered in March (5 A220, 4 A320, 7 A321, 2 A330, 3 A350) and quarter-to-date totals of 16 A220, 13 A320, 38 A321, 2 A330 and 6 A350 (A321 largest share). Boeing has 8 March deliveries and 105 quarter-to-date, but March figures are depressed by wiring defects on ~25 737 MAX aircraft (scratches on electrical wiring bundles from a machining error), posing near-term delivery risk for Boeing. Barclays released these delivery estimates as part of its Airbus coverage.

Analysis

A near-term manufacturing/quality credibility shock at a major US OEM has immediate winners and losers beyond headline delivery tallies: airlines facing shortfalls will accelerate lease renewals, extend wet-lease relationships, and push for greater commonality in future orders — a multi-quarter tailwind for lessors and for OEMs/suppliers that can demonstrate predictable output. The competitor with current spare narrow‑body capacity (and proven ramp capability) stands to capture incremental share on aircraft selection decisions made this year, not just through new orders but via accelerated conversions and long-term fleet strategy shifts that lock in engine and MRO spend for a decade.

The institutional risk stack is layered. In the next 30–90 days expect volatile sentiment and potential order momentum shifts; regulatory and audit milestones over 3–9 months are the decisive catalysts that can either normalize market fear or cement a multi-quarter production re-rating. Structural reversals require visible remediation across quality control, supplier requalification, and consistent delivery cadence — absent those, residual values and financing spreads for affected models can compress for 12–24 months, increasing lessee pressure and secondary-market heat.

The consensus reaction today skews headline-focused and underweights two second‑order opportunities: (1) volatility in supplier cashflows and MRO demand (benefiting nimble aftermarket specialists and lessors) and (2) a temporary window where option volatility on the OEM is overstated relative to the probability of a partial near-term resolution. That creates asymmetric trade setups — protect portfolios with time‑priced downside insurance and exploit pair trades that isolate company credibility risk vs durable demand for narrow‑body capacity.

Key Decisions for Investors

• Short BA equity (size 2–3% NAV): establish short over 1–2 days on strength, target 25% downside in 6–12 months, hard stop at +12% vs entry. Rationale: credibility and delivery cadence risk will reprice valuation multiples; reward ~8–10% NAV if target met, loss limited by stop.
• Buy BA 9–12 month puts (30% OTM), allocate 1–1.5% NAV to option premium: asymmetric payoff if credibility issues persist >3 months; expected payoff 4–8x if equity drops >20%. Pair with selling shorter-dated high‑IV calls (covered or call spread) to finance premium if comfortable with capped upside risk.
• Relative trade — short BA / long SMCI (notional balanced 1:1, total exposure 3% NAV each): hedge portfolio cyclicality by expressing conviction that industrial re-rating will lag rotation into high-convexity tech. Timeframe 3–9 months; target pair return +20% if BA underperforms while SMCI re-rates on growth news; cut if SMCI underperforms by 15%.
• Buy BCS 3–6 month call spread (small allocation 1% NAV) around research/earnings windows: play elevated European research-driven flow and potential trading commission tailwinds from aerospace volatility. Target 15–25% upside on the position, max loss = premium paid.
• If looking for a convex hedge rather than outright short: sell BA near-term (30–60 day) strangles size-limited and use proceeds to buy 9–12 month puts — collect premium from immediate IV while maintaining long-dated protection. Keep net vega exposure small (<1% NAV) and monitor IV term structure weekly.